Harlan Amstutz, M.D.
Harlan C. Amstutz, M.D. is the founding director of the Joint Replacement Institute, Professor Emeritus and former Chief of Orthopaedic Surgery at the University of California at Los Angeles. Dr. Amstutz is recognized worldwide as a preeminent orthopaedic surgeon and researcher in the field of joint replacement.
Unlike conventional total hip replacement (THR), hip resurfacing is conservative in that the femoral head and neck of the hip joint are not removed nor is bone removed from the femur. In the case of surface replacement, less bone is also removed from the acetabulum as compared to conventional THR since no polyethylene liner is used.
Minimally Invasive Hip Resurfacing
JRI Research
- 675 National or international presentations.
- 64 Visiting Professorships and named Lectureships
- Member of 27 national and international societies.
- Major research in areas of bioengineering, biomechanics and biomaterials particularly as they relate to joint replacement and the prevention of complications.
- Developer of several of the most successful total hip replacement devices since 1970.
- Innovator and developer of the Conserve® Hemisurface and Conserve® Plus hip surface arthroplasty utilizing metal-metal bearing technology.
- Developer of successful shoulder replacement.
- Holder of 13 patents.
- Author or co-author of nearly 500 scientific publications and abstracts.
- Recipient of seven national awards for excellence in basic research in hip and knee biomechanics, biomaterials and innovations in joint replacement.
- Recipient of the UCLA Alumni Professional Achievement Award.
- Editor of Hip Arthroplasty, a widely acclaimed reference book on the subject of hip replacement and reconstruction.
- Served as chairman of the Gordon Conference of Biomaterials, President of the North American Hip Society, President of the Orthopaedic Research Society, President of the Association of Bone and Joint Surgeons, President of the Association of Orthopaedic Chairman, President of the American Orthopaedic Association and President of the International Hip Society.
- Elected to the Royal College of Surgeons of England as an Honorary Fellow (one of only seven American orthopaedic surgeons so honored).
- Named by peers regularly in the publication entitled The Best Doctors in America
- Honorary Member of German Orthopaedic Society
- AOA-Zimmer Award for Distinguished Contribution to Orthopaedics
Thomas Schmalzried, M.D.
Thomas P. Schmalzried, M.D., Associate Director of the Joint Replacement Institute at St. Vincent Medical Center, is a board-certified orthopaedic surgeon specializing in the diagnosis and treatment of diseases of the adult hip and knee, with a focus on total joint replacement. The author of over one hundred scientific manuscripts, he is a three-time recipient of the John Charnley Award for pioneering research in joint arthroplasty.
Schmalzried is on the editorial review board of several scientific journals and is the Joint Replacement Section Editor for Orthopedics Today, the most widely read orthopaedic periodical. He has served on the Board of Directors of the Western Orthopaedic Association (1996-97), the American Academy of Orthopaedic Surgeons (1998-2000), the Orthopaedic Research Society (2000-present) and the Association of Arthritic Hip and Knee Surgeons (2000-present).
Dr. Schmalzried attended Stanford University on a basketball scholarship and was a 3-year varsity letterman. He graduated in 1980 with honors and distinction, and was elected to membership in the Phi Beta Kappa academic society. Dr. Schmalzried attended UCLA Medical School and was elected to membership in the academic medical society, Alpha Omega Alpha. He did his internship in surgery and residency in orthopaedics at UCLA. In 1985-86, Dr. Schmalzried was a research fellow in joint replacement, sponsored by the National Institutes of Health (NIH). Following his residency at UCLA in 1990-1991, Dr. Schmalzried was the Hip and Implant Fellow at Harvard University and an Assistant in Orthopaedic Surgery at the Massachusetts General Hospital.
In addition to his academic pursuits, Dr. Schmalzried is a recognized expert in orthopedic managed care and he is a managing partner of California Orthopedic and Sports Medicine Associates, a specialty IPA and managed care consulting firm.
H. Michael Mynatt, M.D.
Dr. H. Michael Mynatt is a diplomat of the American Board of Orthopaedic Surgeons, Associate Clinical Professor Emeritus at the University of Southern California Orthopaedic Department and has served on the medical staff of St. Vincent Medical Center for over 20 years.
After earning his medical degree from the Medical College of Wisconsin, he completed his internship at the University of California, San Diego. Dr. Mynatt served 2 years of active duty with the U.S. Navy before returning to the Medical College of Wisconsin for orthopaedic residency.
Dr. Mynatt has performed more than 3,000 hip and knee replacement surgeries. He has served with Operation Walk Charity Program traveling to Nepal, Peru, Mexico and Guatemala. An active member of the USC Department of Surgery Volunteer Faculty for over 20 years and has twice been honored as Teacher of the Year.
Areas of Interest and Research include:
Total Hip Arthroplasty
- ALTERNATIVE BEARING SURFACES for Active Patients
- BIG FEMORAL HEADS for restoration of Hip Motion with Minimal Risk of Dislocation
- MINI INCISION TECHNOLOGY for Rapid Recovery of Muscle Function
Total Knee Arthroplasty
- HIGH FLEXION KNEE DESIGN
- MUSCLE PRESERVING APPROACHES
- ALTERNATIVES TO FULL KNEE REPLACEMENT including UniCompartmental and BiCompartmental Arthroplasty
The staff of JRI is engaged in various research studies, including: improving long term joint replacement durability by selective use of new replacement bearing technology, histological characterization of implant fixation, relationship between wear debris and aseptic loosening.
Copyright 2005 Joint Replacement Institute Los Angeles, CA · (213) 484-7600 · JRIinfo@dochs.org
